… (HER2+) advanced metastatic breast cancer (mBC) with liver … compared with the lapatinib (Tykerb; GSK)-capecitabine regimen. … positive liver metastatic advanced breast cancer. Front Oncol. April … for HER2-positive metastatic breast cancer: a systematic review …

… receptor-positive (HER2+) breast cancer (BC), according to … understand how PAK5 affects breast cancer, researchers measured its … both trastuzumab and lapatinib (Tykerb; GSK), another targeted … accumulation in HER2-positive breast cancer. Cell Death & …

… treatments specifically targeting HER2-positive breast cancer brain metastases,” the authors explained … patients with no prior lapatinib (Tykerb) exposure, and cohort 3B ( … sequencing treatments for patients with breast cancer brain metastases,” the authors …

… T-DM1, lapatinib (Tykerb) plus capecitabine, and … with HER2-positive metastatic breast cancer for brain metastases … HER2+ Breast Cancer. Presented at: 42nd Annual Miami Breast Cancer Conference. … HER2-positive metastatic breast cancer and brain metastases: …

… ) benefit vs lapatinib (Tykerb) plus capecitabine for the … HER2-positive advanced breast cancer who experienced disease … or metastatic breast cancer or locally advanced breast cancer not amenable … HER2-positive advanced breast cancer. Signal Transduct Target …

… and EGFR-positive (EGFR+) breast cancer (BC). The data … cells. The anti-breast cancer effect happens when … tanshinlactone worked against breast cancer cells that resist (Tykerb; Novartis), a … Tanshinlactone triggers methuosis in breast cancer cells via NRF2 …

… treatments for early breast cancer were administered either … HER2-positive early breast cancer who receive neoadjuvant … in HER2-positive metastatic breast cancer,” Geyer said. “ … Tykerb, Novartis] in patients with metastatic, HER2-positive breast cancer …

… breast cancer (BC). At the 2024 San Antonio Breast Cancer … PFS compared with lapatinib (Tykerb; Novartis) plus capecitabine … advanced or metastatic breast cancer (EMILIA). ClinicalTrials. … (HER3) positive metastatic breast cancer. ClinicalTrials.gov Identifier: …

… patients with HER2-positive breast cancer. Ado-trastuzumab emtansine, … with HER2-positive early breast cancer and residual invasive … patients with difficult-to-treat breast cancers. Transcription: 0:09 | … than capecitabine and lapatinib [Tykerb] as based on …

… for invasive breast cancer. The NCCN Breast Cancer Risk Reduction … metastatic breast cancer; and treatment of advanced breast cancer … decrease in breast cancers. Guidance on breast cancer screening in … November 2023. 28. Tykerb (lapatinib) product information. …